Caldwell Sutter Capital Inc. Grows Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Caldwell Sutter Capital Inc. boosted its holdings in Kenvue Inc. (NYSE:KVUE) by 15.9% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 28,564 shares of the company’s stock after purchasing an additional 3,908 shares during the quarter. Caldwell Sutter Capital Inc.’s holdings in Kenvue were worth $685,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. LaFleur & Godfrey LLC increased its holdings in shares of Kenvue by 29.8% in the 4th quarter. LaFleur & Godfrey LLC now owns 81,300 shares of the company’s stock valued at $1,736,000 after acquiring an additional 18,650 shares during the last quarter. Stratos Wealth Partners LTD. increased its stake in Kenvue by 4.7% in the fourth quarter. Stratos Wealth Partners LTD. now owns 13,461 shares of the company’s stock valued at $287,000 after purchasing an additional 601 shares during the last quarter. Apollon Wealth Management LLC raised its holdings in Kenvue by 16.5% during the fourth quarter. Apollon Wealth Management LLC now owns 11,701 shares of the company’s stock worth $250,000 after purchasing an additional 1,653 shares in the last quarter. Savant Capital LLC lifted its position in shares of Kenvue by 5.2% during the 4th quarter. Savant Capital LLC now owns 16,241 shares of the company’s stock worth $347,000 after buying an additional 798 shares during the last quarter. Finally, Focus Financial Network Inc. boosted its holdings in shares of Kenvue by 10.5% in the 4th quarter. Focus Financial Network Inc. now owns 11,529 shares of the company’s stock valued at $246,000 after buying an additional 1,095 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on KVUE. Piper Sandler lifted their price target on shares of Kenvue from $24.00 to $27.00 and gave the stock an “overweight” rating in a research note on Monday, February 24th. Canaccord Genuity Group boosted their target price on Kenvue from $24.00 to $29.00 and gave the company a “buy” rating in a report on Wednesday, March 5th. Evercore ISI initiated coverage on Kenvue in a research note on Monday, March 24th. They set an “in-line” rating and a $25.00 price target on the stock. Redburn Atlantic began coverage on shares of Kenvue in a research note on Thursday, April 10th. They set a “neutral” rating and a $23.50 price target for the company. Finally, UBS Group lifted their price objective on shares of Kenvue from $24.00 to $25.00 and gave the company a “neutral” rating in a research note on Friday, May 9th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $25.33.

Kenvue Stock Down 2.7%

Shares of NYSE:KVUE opened at $21.44 on Friday. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $25.17. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. The firm’s 50-day simple moving average is $23.02 and its 200-day simple moving average is $22.52. The company has a market cap of $41.14 billion, a price-to-earnings ratio of 40.46, a PEG ratio of 2.62 and a beta of 0.98.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.24 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.01. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The firm had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. During the same quarter last year, the firm earned $0.28 earnings per share. The firm’s revenue was down 3.9% compared to the same quarter last year. As a group, equities research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th were paid a $0.205 dividend. The ex-dividend date was Wednesday, May 14th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.82%. Kenvue’s dividend payout ratio (DPR) is presently 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.